S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
CGC   20.21 (-2.65%)
NVDA   190.49 (-1.96%)
MU   43.47 (-4.46%)
BABA   169.13 (-4.37%)
GE   8.96 (-0.88%)
TSLA   256.95 (-1.92%)
AMD   30.97 (-0.55%)
T   38.47 (+1.75%)
F   9.29 (+1.98%)
ACB   3.68 (-5.40%)
PRI   123.53 (-0.44%)
NFLX   275.30 (-6.15%)
BAC   30.35 (+0.30%)
GILD   64.91 (-0.49%)
DIS   130.89 (-1.12%)
S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
CGC   20.21 (-2.65%)
NVDA   190.49 (-1.96%)
MU   43.47 (-4.46%)
BABA   169.13 (-4.37%)
GE   8.96 (-0.88%)
TSLA   256.95 (-1.92%)
AMD   30.97 (-0.55%)
T   38.47 (+1.75%)
F   9.29 (+1.98%)
ACB   3.68 (-5.40%)
PRI   123.53 (-0.44%)
NFLX   275.30 (-6.15%)
BAC   30.35 (+0.30%)
GILD   64.91 (-0.49%)
DIS   130.89 (-1.12%)
Log in

Sangamo Therapeutics News Headlines (NASDAQ:SGMO)

$8.31
-0.32 (-3.71 %)
(As of 10/18/2019 04:00 PM ET)
Today's Range
$8.27
Now: $8.31
$8.66
50-Day Range
$7.86
MA: $9.79
$11.19
52-Week Range
$6.26
Now: $8.31
$14.58
Volume847,671 shs
Average Volume1.87 million shs
Market Capitalization$961.26 million
P/E RatioN/A
Dividend YieldN/A
Beta2.81

Headlines

Sangamo Therapeutics (NASDAQ SGMO) News Headlines

Source:
DateHeadline
Sangamo Therapeutics Inc (NASDAQ:SGMO) Receives Consensus Recommendation of "Hold" from AnalystsSangamo Therapeutics Inc (NASDAQ:SGMO) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - October 17 at 10:15 AM
$14.01 Million in Sales Expected for Sangamo Therapeutics Inc (NASDAQ:SGMO) This Quarter$14.01 Million in Sales Expected for Sangamo Therapeutics Inc (NASDAQ:SGMO) This Quarter
www.americanbankingnews.com - October 17 at 4:12 AM
Sangamo Therapeutics Inc (NASDAQ:SGMO) Expected to Post Earnings of -$0.33 Per ShareSangamo Therapeutics Inc (NASDAQ:SGMO) Expected to Post Earnings of -$0.33 Per Share
www.americanbankingnews.com - October 15 at 3:20 PM
What Kind Of Shareholder Owns Most Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Stock?What Kind Of Shareholder Owns Most Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Stock?
finance.yahoo.com - October 1 at 4:09 PM
Sangamo Therapeutics Appoints Bettina M. Cockroft, MD, MBA, as Senior Vice President and Chief Medical OfficerSangamo Therapeutics Appoints Bettina M. Cockroft, MD, MBA, as Senior Vice President and Chief Medical Officer
finance.yahoo.com - September 30 at 5:07 PM
Sangamo Therapeutics Inc (NASDAQ:SGMO) Expected to Announce Quarterly Sales of $14.01 MillionSangamo Therapeutics Inc (NASDAQ:SGMO) Expected to Announce Quarterly Sales of $14.01 Million
www.americanbankingnews.com - September 24 at 3:03 AM
4D Pharma Appoints Sangamo Therapeutics Boss Macrae To Board4D Pharma Appoints Sangamo Therapeutics Boss Macrae To Board
www.morningstar.co.uk - August 27 at 8:01 PM
Sangamo Therapeutics (SGMO) Shares Cross Below 200 DMASangamo Therapeutics (SGMO) Shares Cross Below 200 DMA
www.nasdaq.com - August 26 at 7:33 PM
Does Sangamo Therapeutics, Inc.'s (NASDAQ:SGMO) CEO Salary Reflect Performance?Does Sangamo Therapeutics, Inc.'s (NASDAQ:SGMO) CEO Salary Reflect Performance?
finance.yahoo.com - August 17 at 8:42 AM
Sangamo Biosciences Inc (SGMO) Q2 2019 Earnings Call TranscriptSangamo Biosciences Inc (SGMO) Q2 2019 Earnings Call Transcript
finance.yahoo.com - August 9 at 10:39 AM
What Youll Want to Know About Sangamo Therapeutics Q2 ResultsWhat You'll Want to Know About Sangamo Therapeutics' Q2 Results
www.fool.com - August 8 at 9:53 AM
What You'll Want to Know About Sangamo Therapeutics' Q2 ResultsWhat You'll Want to Know About Sangamo Therapeutics' Q2 Results
finance.yahoo.com - August 8 at 9:53 AM
Edited Transcript of SGMO earnings conference call or presentation 7-Aug-19 9:00pm GMTEdited Transcript of SGMO earnings conference call or presentation 7-Aug-19 9:00pm GMT
finance.yahoo.com - August 8 at 9:53 AM
Sangamo Q2 revenue down 18%Sangamo Q2 revenue down 18%
seekingalpha.com - August 7 at 10:55 PM
Sangamo Therapeutics Reports Second Quarter 2019 Financial ResultsSangamo Therapeutics Reports Second Quarter 2019 Financial Results
finance.yahoo.com - August 7 at 10:55 PM
Sangamo Therapeutics (SGMO) Reports Q2 Loss, Lags Revenue EstimatesSangamo Therapeutics (SGMO) Reports Q2 Loss, Lags Revenue Estimates
finance.yahoo.com - August 7 at 10:55 PM
Sangamo Therapeutics Q2 2019 Earnings PreviewSangamo Therapeutics Q2 2019 Earnings Preview
seekingalpha.com - August 6 at 11:35 PM
Sangamo Announces Nature Biotechnology Publication of New Strategies for Optimizing the Specificity of Gene Editing NucleasesSangamo Announces Nature Biotechnology Publication of New Strategies for Optimizing the Specificity of Gene Editing Nucleases
finance.yahoo.com - July 29 at 11:43 AM
Shake-Up in Big WeedShake-Up in Big Weed
finance.yahoo.com - July 20 at 9:05 AM
Sangamos Hemophilia A Results Light A Spark And Push Program Into Pfizers HandsSangamo's Hemophilia A Results Light A Spark And Push Program Into Pfizer's Hands
seekingalpha.com - July 17 at 8:41 AM
Why Is Sangamo Therapeutics Moving?Why Is Sangamo Therapeutics Moving?
www.benzinga.com - July 11 at 6:15 PM
Heres Why Sangamo Therapeutics Jumped 23% in JuneHere's Why Sangamo Therapeutics Jumped 23% in June
www.nasdaq.com - July 11 at 6:15 PM
Sangamo Therapeutics Rises on Positive Clinical Trial ResultsSangamo Therapeutics Rises on Positive Clinical Trial Results
finance.yahoo.com - July 9 at 6:34 PM
Sangamo Shares Soar as Hemophilia Drug Shows PromiseSangamo Shares Soar as Hemophilia Drug Shows Promise
www.thestreet.com - July 8 at 6:38 PM
Sangamo Therapeutics News: SGMO Stock Surges on Gene Therapy StudySangamo Therapeutics News: SGMO Stock Surges on Gene Therapy Study
investorplace.com - July 8 at 3:39 PM
Sangamo up 14% premarket on positive hemophilia A gene therapy dataSangamo up 14% premarket on positive hemophilia A gene therapy data
seekingalpha.com - July 8 at 8:30 AM
Sangamo Therapeutics (SGMO) Shares Cross Above 200 DMASangamo Therapeutics (SGMO) Shares Cross Above 200 DMA
www.nasdaq.com - July 3 at 6:41 PM
Sangamo Therapeutics, Inc.: Upcoming News And Q2 Results Will Send The Stock SoaringSangamo Therapeutics, Inc.: Upcoming News And Q2 Results Will Send The Stock Soaring
seekingalpha.com - July 2 at 6:31 PM
Implied Volatility Surging for Sangamo (SGMO) Stock OptionsImplied Volatility Surging for Sangamo (SGMO) Stock Options
finance.yahoo.com - July 2 at 6:31 PM
A hemophilia patient hero at zero, BioMarin to seek FDA OK for gene therapy. But will the effect last?A hemophilia patient hero at zero, BioMarin to seek FDA OK for gene therapy. But will the effect last?
finance.yahoo.com - May 28 at 6:11 PM
Sangamo Therapeutics Announces Presentations At Upcoming Scientific, Medical And Investor ConferencesSangamo Therapeutics Announces Presentations At Upcoming Scientific, Medical And Investor Conferences
finance.yahoo.com - May 15 at 8:36 PM
Sangamo Therapeutics finance chief bids adieuSangamo Therapeutics finance chief bids adieu
seekingalpha.com - May 14 at 8:50 AM
Sangamo Therapeutics Announces Participation In The Bank Of America Merrill Lynch 2019 Health Care ConferenceSangamo Therapeutics Announces Participation In The Bank Of America Merrill Lynch 2019 Health Care Conference
finance.yahoo.com - May 10 at 8:35 AM
Heres Why Sangamo Therapeutics Fell as Much as 13.6% TodayHere's Why Sangamo Therapeutics Fell as Much as 13.6% Today
www.fool.com - May 9 at 7:35 PM
Sangamo Therapeutics, Inc. (SGMO) CEO Sandy Macrae on Q1 2019 Results - Earnings Call TranscriptSangamo Therapeutics, Inc. (SGMO) CEO Sandy Macrae on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 9 at 8:31 AM
What You Need to Know About Sangamo Therapeutics' Q1 Earnings ResultsWhat You Need to Know About Sangamo Therapeutics' Q1 Earnings Results
finance.yahoo.com - May 9 at 8:31 AM
Edited Transcript of SGMO earnings conference call or presentation 8-May-19 9:00pm GMTEdited Transcript of SGMO earnings conference call or presentation 8-May-19 9:00pm GMT
finance.yahoo.com - May 9 at 8:31 AM
Sangamo Q1 revenues down 36%Sangamo Q1 revenues down 36%
seekingalpha.com - May 8 at 7:29 PM
Sangamo Therapeutics (SGMO) Reports Q1 Loss, Lags Revenue EstimatesSangamo Therapeutics (SGMO) Reports Q1 Loss, Lags Revenue Estimates
finance.yahoo.com - May 8 at 7:29 PM
Sangamo Therapeutics Q1 Earnings PreviewSangamo Therapeutics Q1 Earnings Preview
seekingalpha.com - May 7 at 6:51 PM
If You Had Bought Sangamo Therapeutics (NASDAQ:SGMO) Stock Three Years Ago, You Could Pocket A 93% Gain TodayIf You Had Bought Sangamo Therapeutics (NASDAQ:SGMO) Stock Three Years Ago, You Could Pocket A 93% Gain Today
finance.yahoo.com - May 5 at 5:38 PM
Here’s What Hedge Funds Think About Sangamo Therapeutics, Inc. (SGMO)Here’s What Hedge Funds Think About Sangamo Therapeutics, Inc. (SGMO)
finance.yahoo.com - May 2 at 7:52 PM
Sangamo Therapeutics Announces First Quarter 2019 Conference Call And WebcastSangamo Therapeutics Announces First Quarter 2019 Conference Call And Webcast
finance.yahoo.com - May 1 at 7:21 PM
Sangamo (SGMO) Q1 Earnings: Whats in Store for the Stock?Sangamo (SGMO) Q1 Earnings: What's in Store for the Stock?
finance.yahoo.com - April 29 at 6:37 PM
Sangamo Therapeutics Announces Presentations At 2019 Annual Meeting Of The American Society Of Gene & Cell TherapySangamo Therapeutics Announces Presentations At 2019 Annual Meeting Of The American Society Of Gene & Cell Therapy
finance.yahoo.com - April 15 at 7:16 PM
Comparing Sangamo’s and Amarin’s Revenue GrowthComparing Sangamo’s and Amarin’s Revenue Growth
finance.yahoo.com - April 8 at 7:42 PM
What’s Expected for Sangamo’s and Amarin’s EPSWhat’s Expected for Sangamo’s and Amarin’s EPS
finance.yahoo.com - April 8 at 7:42 PM
Sangamo- Biotech "Fires on All Cylinders"Sangamo- Biotech "Fires on All Cylinders"
finance.yahoo.com - April 5 at 7:39 PM
Sangamo Unleashes Stock OfferingSangamo Unleashes Stock Offering
www.marketwatch.com - April 4 at 7:49 PM
Sangamo down 6% on pricing stock offeringSangamo down 6% on pricing stock offering
seekingalpha.com - April 4 at 7:49 PM
This page was last updated on 10/18/2019 by MarketBeat.com Staff

Featured Article: Dogs of the Dow

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel